Suppr超能文献

调制电子放射治疗与常规电子束推量照射和容积调强光子弧形治疗在乳腺癌瘤床推量中的比较。

Comparison of modulated electron radiotherapy to conventional electron boost irradiation and volumetric modulated photon arc therapy for treatment of tumour bed boost in breast cancer.

机构信息

Medical Physics Unit, McGill University, Montreal, Quebec, Canada.

出版信息

Radiother Oncol. 2011 Aug;100(2):253-8. doi: 10.1016/j.radonc.2011.05.081. Epub 2011 Jul 6.

Abstract

BACKGROUND AND PURPOSE

To compare few leaf electron collimator (FLEC)-based modulated electron radiotherapy (MERT) to conventional direct electron (DE) and volumetric modulated photon arc therapy (VMAT) for the treatment of tumour bed boost in breast cancer.

MATERIALS AND METHODS

Fourteen patients with breast cancer treated by lumpectomy and requiring post-operative whole breast radiotherapy with tumour bed boost were planned retrospectively using conventional DE, VMAT and FLEC-based MERT. The planning goal was to deliver 10Gy to at least 95% of the tumour bed volume. Dosimetry parameters for all techniques were compared.

RESULTS

Dose evaluation volume (DEV) coverage and homogeneity were best for MERT (D(98)=9.77Gy, D(2)=11.03Gy) followed by VMAT (D(98)=9.56Gy, D(2)=11.07Gy) and DE (D(98)=9.81Gy, D(2)=11.52Gy). Relative to the DE plans, the MERT plans predicted a reduction of 35% in mean breast dose (p<0.05), 54% in mean lung dose (p<0.05) and 46% in mean body dose (p<0.05). Relative to the VMAT plans, the MERT plans predicted a reduction of 24%, 36% and 39% in mean breast dose, heart dose and body dose, respectively (p<0.05).

CONCLUSIONS

MERT plans were a considerable improvement in dosimetry over DE boost plans. There was a dosimetric advantage in using MERT over VMAT for increased DEV conformity and low-dose sparing of healthy tissue including the integral dose; however, the cost is often an increase in the ipsilateral lung high-dose volume.

摘要

背景与目的

比较少叶电子准直器(FLEC)调制电子放射治疗(MERT)与传统直接电子(DE)和容积调强光子弧形治疗(VMAT)在乳腺癌肿瘤床加量中的应用。

材料与方法

回顾性分析了 14 例接受保乳手术后需要全乳放疗加肿瘤床加量的乳腺癌患者,分别采用传统 DE、VMAT 和 FLEC 调制的 MERT 进行计划。计划目标是将 10Gy 剂量送达肿瘤床体积的至少 95%。比较了所有技术的剂量学参数。

结果

MERT 的剂量评价体积(DEV)覆盖度和均匀度最佳(D(98)=9.77Gy,D(2)=11.03Gy),其次是 VMAT(D(98)=9.56Gy,D(2)=11.07Gy)和 DE(D(98)=9.81Gy,D(2)=11.52Gy)。与 DE 计划相比,MERT 计划预测平均乳腺剂量降低 35%(p<0.05),平均肺剂量降低 54%(p<0.05),平均身体剂量降低 46%(p<0.05)。与 VMAT 计划相比,MERT 计划预测平均乳腺剂量、心脏剂量和身体剂量分别降低 24%、36%和 39%(p<0.05)。

结论

与 DE 加量计划相比,MERT 计划在剂量学上有显著改善。与 VMAT 相比,MERT 在增加 DEV 适形度和降低健康组织(包括积分剂量)低剂量方面具有优势;然而,其代价通常是同侧肺高剂量体积的增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验